Blue Whale Capital LLP Has $78.50 Million Stock Holdings in Danaher Corporation $DHR

Blue Whale Capital LLP lifted its position in shares of Danaher Corporation (NYSE:DHR) by 14.8% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 397,394 shares of the conglomerate’s stock after buying an additional 51,148 shares during the period. Danaher comprises 5.1% of Blue Whale Capital LLP’s investment portfolio, making the stock its 8th largest position. Blue Whale Capital LLP owned 0.06% of Danaher worth $78,501,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Red Tortoise LLC boosted its holdings in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after acquiring an additional 98 shares during the period. Ramirez Asset Management Inc. bought a new position in shares of Danaher in the 2nd quarter worth approximately $40,000. Costello Asset Management INC purchased a new stake in Danaher in the first quarter worth $41,000. Strengthening Families & Communities LLC boosted its stake in Danaher by 81.4% during the first quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock worth $52,000 after acquiring an additional 114 shares in the last quarter. Finally, Saudi Central Bank bought a new stake in shares of Danaher in the 1st quarter worth approximately $52,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

DHR has been the topic of several recent analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Royal Bank Of Canada set a $241.00 target price on shares of Danaher in a research report on Tuesday, September 2nd. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Saturday. Weiss Ratings restated a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Finally, Rothschild Redb lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $243.39.

Danaher Price Performance

NYSE:DHR opened at $230.82 on Wednesday. The stock has a market cap of $163.04 billion, a PE ratio of 47.59, a P/E/G ratio of 3.28 and a beta of 0.81. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The business’s 50-day simple moving average is $210.16 and its two-hundred day simple moving average is $202.63. Danaher Corporation has a 52 week low of $171.00 and a 52 week high of $258.23.

Danaher (NYSE:DHR) last released its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The firm’s revenue was up 4.4% on a year-over-year basis. During the same quarter last year, the business posted $1.71 earnings per share. As a group, analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were given a dividend of $0.32 per share. The ex-dividend date was Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 3,298 shares of Danaher stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total value of $746,997.00. Following the sale, the director directly owned 20,762 shares in the company, valued at approximately $4,702,593. The trade was a 13.71% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Brian W. Ellis sold 21,776 shares of the business’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the completion of the sale, the senior vice president owned 14,553 shares in the company, valued at approximately $3,190,454.19. The trade was a 59.94% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 30,248 shares of company stock valued at $6,609,663. 11.10% of the stock is currently owned by corporate insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.